Brief: Dawnrays Pharmaceutical says HY profit attributable RMB131.5 mln vs RMB 154.3 mln
26/08/2016 05:23
Aug 26 (Reuters) - Dawnrays Pharmaceutical Holdings Ltd 2348.HK : * Says HY profit attributable RMB131.5 million versus RMB 154.3 million * Says the board has resolved to declare an interim dividend of hk$0.03 per share * Says HY revenue RMB 418.4 million versus RMB 488.8 million Source text for Eikon urn:newsml:reuters.com:*:nHKS6rZwqw ((Further company coverage: 2348.HK )) ((Bangalore.newsroom@thomsonreuters.com))
Recent news on Dawnrays Pharmaceutical (Holdings)
See all newsBrief: Dawnrays Pharmaceutical Says Suzhou Dawnrays Commits To Invest Up To RMB100 Mln In Partnership
Brief: Dawnrays Pharmaceutical (Holdings) Final Dividend Of Hk$0.048 Per Share
Brief: Dawnrays Pharmaceutical Reports HY Net Income Attributable Of RMB104.6 MLN
Brief: Dawnrays Pharmaceutical (Holdings) Posts FY Profit Attributable Of Rmb564.9 Million
Brief: Dawnrays Pharmaceutical (Holdings) Appoints Yu Liwei To Act As CEO